Wiskott–Aldrich syndrome protein expression in female WAS carriers: A flow cytometry study from North India
Suprit Basu,Rashmi Rikhi,Kanika Arora,Vibhu Joshi,Saniya Sharma,Amit Rawat,Surjit Singh,Deepti Suri
DOI: https://doi.org/10.1002/pbc.30972
2024-03-26
Pediatric Blood & Cancer
Abstract:Introduction Wiskott–Aldrich syndrome (WAS) is a rare X‐linked inborn error of immunity characterized by microthrombocytopenia, infections, eczema, and increased predisposition to develop autoimmunity and malignancy. Flow cytometric assay for determining WAS protein (WASp) is a rapid and cost‐effective tool for detecting patients. However, very few studies described WASp expression in female carriers. Most WAS carriers are clinically asymptomatic. Active screening of female family members helps identify female carriers, distinguish de novo mutations, and to select appropriate donor prior to curative stem cell transplantation. This study was undertaken to evaluate the diagnostic capability of flow cytometry‐based WASp expression in peripheral blood cells to identify carriers and compare WASp expression in different blood cell lineages. Patients and methods Female patients, heterozygous for WAS gene, were enrolled in this study conducted at Pediatric Allergy Immunology Unit, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Flow cytometric assessment of WASp expression in lymphocytes, monocytes, and neutrophils was carried out and compared with healthy control and affected patients. The results were expressed in delta (Δ) median fluorescence intensity (MFI) as well as stain index (SI), which is the ratio of ΔMFI of patient and ΔMFI of control. Results Thirteen mothers and two sisters of genetically confirmed WAS patients were enrolled in the study. All enrolled females were clinically asymptomatic and did not have microthrombocytopenia. Low WASp expression (SI
oncology,pediatrics,hematology